仕事内容

仕事内容変更範囲

会社の指示する業務

職位

ー

募集人数

2人

選考内容

選考プロセス

適性試験：無し 、 面接回数：2回

代表者名

代表取締役　Nick Sinackevich (シナケヴィッチ・ニック)　PSI Japan Country Manager: Sayaka Kaji (梶さやか)

設立

2024年9月

従業員数

30名（2026年2月）

資本金

10,000,000円

本社所在地

〒103-0025 東京都千代田区丸の内二丁目6番1号 丸の内パークビルディング8階xLINK丸の内（区画No.15）

株式公開

日系・外資

外資

企業URL

事業内容

PSI is a leading Contract Research Organization (CRO) with over 25 years of experience in the pharmaceutical industry. Originating from Switzerland, PSI is a privately owned, full-service CRO with a global reach, supporting clinical trials across multiple countries and continents. Our reputation for being highly selective about the projects we undertake highlights our commitment to delivering high-quality, timely services across a broad spectrum of therapeutic indications.

In an industry where cost-cutting and layoffs are common, PSI stands out as a stable and secure workplace. Our dedication to stability is evident in our exceptionally high repeat and referral business rate and minimal staff turnover. Many of our colleagues have been with us for over 15 years, contributing to our long-standing traditions and history. Our expansion into Japan continues this legacy, and we seek team members who will grow with us for the long term.
At PSI, we foster an environment where a diverse range of colleagues feel welcomed and valued. Our inclusive culture is a cornerstone of our success, enabling us to attract and retain top talent globally.

We are not just about conducting clinical trials; we are about building a community where every team member has the opportunity to thrive and contribute to groundbreaking advancements in the pharmaceutical industry.

事業に関する特色

■Mission
Our mission is to be the best CRO in the world as measured by our employees, clients, sites, and vendors.

Employees come first because being in the people business, we know only happy employees can make happy clients, sites, and vendors. In fact, we do not like the word “employees” and hardly ever use it. We prefer to say “teammates”.

We work in teams, and that shapes our collective mindset. Connection and interdependence are important to us and we devote time, attention, and funds to bring teams together. Many newcomers quickly comment on the uncommon team atmosphere they perceive here from day one.

■Management
PSI is privately owned by a group of managers who set it up a quarter of a century ago and still come to work every day.

These folks succeeded in keeping the company fully independent. In our industry, this is unique and gives us great advantage and freedom.

The power distance within PSI is very short. It is routine for our upper level officers to be involved in all sorts of dialogue with teammates of all levels. We make a point to be approachable, receptive to new ideas, and open to feedback. After all, we want to identify our weaknesses before the market does.

Both our country and functional management have a fair degree of autonomy in making decisions and creating an engaging working environment. They have operational freedom to make nuanced country-and department-specific adjustments while nurturing the global PSI culture that unites us across six continents.


■The PSI Advantage
PSI CRO has received 2024 CRO Leadership Awards in the categories of Expertise, Quality, Compatibility, and Reliability in the Overall (combined Big and Small Pharma) respondent group. This is the seventh consecutive year that PSI has received leadership awards presented by Clinical Leader and Life Science Connect based on research conducted by ISR. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.

会社の特色

ー

その他の特色

ー